|
End-of-day quote
Shenzhen S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 4.520 CNY | +0.67% |
|
-3.21% | +3.91% |
| 09-17 | Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream | MT |
| 09-01 | Guizhou Bailing Group Pharmaceutical Gets China Clinical Trial Approval for COPD Drug | MT |
| Market Cap | 6.17B 922M 820M 760M 691M 1.3B 87.51B 1.33B 9.13B 3.58B 45.67B 3.46B 3.39B 146B | P/E 2024 |
193x | P/E 2025 | -54.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.04B 1.05B 936M 867M 789M 1.49B 99.92B 1.51B 10.43B 4.09B 52.14B 3.95B 3.87B 166B | EV / Sales 2024 |
1.74x | EV / Sales 2025 | 2.23x |
| Free-Float |
66.81% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.67% | ||
| 1 week | -3.21% | ||
| Current month | -3.62% | ||
| 1 month | +1.57% | ||
| 3 months | -4.84% | ||
| 6 months | -10.14% | ||
| Current year | +3.91% |
| 1 week | 4.48 |  | 4.62 |
| 1 month | 4.44 | | 4.8 |
| Current year | 4.08 | | 5.47 |
| 1 year | 4.08 | | 6.43 |
| 3 years | 2.98 | | 8.8 |
| 5 years | 2.98 | | 11.97 |
| 10 years | 2.98 | | 23.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Niu
CEO | Chief Executive Officer | 56 | 2015-04-01 |
Hong Xing Li
DFI | Director of Finance/CFO | 41 | 2020-12-28 |
Pei Chen
PRN | Corporate Officer/Principal | 42 | 2014-01-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Min Niu
CHM | Chairman | 56 | 2026-03-26 |
Yong Jiang
BRD | Director/Board Member | 58 | 2007-12-24 |
Pei Chen
BRD | Director/Board Member | 42 | 2014-01-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/21/20 | Sell | Chairman | 1,940,600 | 0.2495% | ||
| 9/18/20 | Sell | Director | 3,670,000 | 0.4719% | ||
| 9/18/20 | Sell | Chairman | 296,500 | 0.0381% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.67% | -3.21% | -16.45% | -46.64% | 916M | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,116B | |
| +0.90% | -2.25% | +33.02% | +62.23% | 610B | |
| +0.71% | +3.24% | +25.81% | +93.86% | 501B | |
| +0.52% | +0.24% | +73.92% | +40.15% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +4.25% | +46.21% | +50.76% | 235B | |
| -0.75% | +3.32% | +32.53% | +97.21% | 195B | |
| Average | +0.08% | +4.67% | +30.02% | +50.60% | 393.07B | |
| Weighted average by Cap. | +0.29% | +4.93% | +39.15% | +71.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.83B 572M 508M 471M 429M 809M 54.26B 822M 5.66B 2.22B 28.31B 2.15B 2.1B 90.26B | 3.05B 456M 405M 375M 342M 644M 43.24B 655M 4.51B 1.77B 22.57B 1.71B 1.67B 71.93B |
| Net income | 33.62M 5.02M 4.47M 4.14M 3.77M 7.11M 477M 7.22M 49.76M 19.51M 249M 18.86M 18.46M 793M | -104M -15.6M -13.86M -12.85M -11.69M -22.06M -1.48B -22.42M -154M -60.56M -772M -58.54M -57.29M -2.46B |
| Net Debt | 1.4B 209M 186M 172M 157M 296M 19.86B 301M 2.07B 813M 10.36B 785M 769M 33.04B | 875M 131M 116M 108M 97.99M 185M 12.41B 188M 1.29B 508M 6.47B 491M 480M 20.64B |
Employees
5,715
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | CN¥4.520 | +0.67% | 4,847,800 |
| 26-10-15 | CN¥4.490 | -1.32% | 5,715,253 |
| 26-10-14 | CN¥4.550 | 0.00% | 3,995,400 |
| 26-10-13 | CN¥4.550 | 0.00% | 4,518,600 |
| 26-10-12 | CN¥4.550 | -1.30% | 5,665,700 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002424 Stock
Select your edition
All financial news and data tailored to specific country editions
